Clinical Trials
2 trialsNCT06149481 2026-06-05
Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)
National Institutes of Health Clinical Center (CC)
Phase 1/2 Recruiting
NCT07488884 2026-04-29
ResQ108B-PANC
ImmunityBio, Inc.
Phase 1 Not yet recruiting